122 related articles for article (PubMed ID: 18766253)
1. Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apo A-II.
Atta M; Crook D; Shafique F; Johnston DG; Godsland IF
Thromb Haemost; 2008 Sep; 100(3):391-6. PubMed ID: 18766253
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.
Chan DC; Watts GF; Ooi EM; Chan DT; Wong AT; Barrett PH
Metabolism; 2011 Oct; 60(10):1482-7. PubMed ID: 21550083
[TBL] [Abstract][Full Text] [Related]
4. A Caucasian male with very low blood cholesterol and low apoA-II without evidence of atherosclerosis.
Park SH; Kim JR; Park JE; Cho KH
Eur J Clin Invest; 2007 Apr; 37(4):249-56. PubMed ID: 17373959
[TBL] [Abstract][Full Text] [Related]
5. Association between EGF and lipid concentrations: a benefit role in the atherosclerotic process?
Berrahmoune H; Lamont JV; Herbeth B; Lambert D; Masson C; McPhillips M; Fitzgerald PS; Visvikis-Siest S
Clin Chim Acta; 2009 Apr; 402(1-2):196-8. PubMed ID: 19167371
[TBL] [Abstract][Full Text] [Related]
6. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
[TBL] [Abstract][Full Text] [Related]
7. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A
Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645
[TBL] [Abstract][Full Text] [Related]
8. Factor VII coagulant activity in relation to serum lipoproteins and dietary fat in middle-aged men.
Väisänen S; Rankinen T; Penttilä I; Rauramaa R
Thromb Haemost; 1995 Mar; 73(3):435-8. PubMed ID: 7667825
[TBL] [Abstract][Full Text] [Related]
9. Association of coagulation factor VII with the risk of myocardial infarction in the Chinese.
Cai Q; Chen J; Ma H; Song J; Xu M
Chin Med J (Engl); 2000 Dec; 113(12):1059-63. PubMed ID: 11776135
[TBL] [Abstract][Full Text] [Related]
10. Relation of cyclosporine blood levels to adverse effects on lipoproteins.
Kuster GM; Drexel H; Bleisch JA; Rentsch K; Pei P; Binswanger U; Amann FW
Transplantation; 1994 May; 57(10):1479-83. PubMed ID: 8197611
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations.
Wang Z; Rowley K; Best J; McDermott R; Taylor M; O'Dea K
Metabolism; 2007 May; 56(5):629-35. PubMed ID: 17445537
[TBL] [Abstract][Full Text] [Related]
12. Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.
Jastrzebska M; Torbus-Lisiecka B; Pieczul-Mróz J; Chelstowski K; Kopciewicz J; Naruszewicz M
Int J Clin Pharmacol Res; 1999; 19(1):19-25. PubMed ID: 10450539
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
[TBL] [Abstract][Full Text] [Related]
14. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
Tian L; Wu J; Fu M; Xu Y; Jia L
Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
[TBL] [Abstract][Full Text] [Related]
15. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
Langsted A; Freiberg JJ; Nordestgaard BG
Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
[TBL] [Abstract][Full Text] [Related]
16. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
[TBL] [Abstract][Full Text] [Related]
18. Association between inflammation, lipid and hemostatic factors in patients with stable angina.
Sagastagoitia JD; Sáez Y; Vacas M; Narváez I; Sáez de Lafuente JP; Molinero E; Magro A; Lafita M; Santos M; Escobar A; Iriarte JA
Thromb Res; 2007; 120(1):53-9. PubMed ID: 16916537
[TBL] [Abstract][Full Text] [Related]
19. Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Zitoun D; Bara L; Basdevant A; Samama MM
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):77-81. PubMed ID: 8548430
[TBL] [Abstract][Full Text] [Related]
20. [The relationships between the lipoprotein profile and rheological-coagulation parameters in patients with hyperlipoproteinemia type II].
Bo M; Molaschi M; Neirotti M; Bonino F; Gottero M; Pedrazzini V; Mainardi S; Fabris F
Recenti Prog Med; 1992 Apr; 83(4):189-93. PubMed ID: 1626110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
